52
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy

, , , , , , & show all
Pages 771-775 | Published online: 21 May 2012

References

  • Collaborative Normal-Tension Glaucoma Study GroupThe effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucomaAm J Ophthalmol19981264985059780094
  • The AGIS InvestigatorsThe Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deteriorationAm J Ophthalmol200013042944011024415
  • DjafariFLeskMRHarasymowyczPJDeterminants of adherence to glaucoma medical therapy in a long-term patient populationJ Glaucoma20091823824219295380
  • InoueKOkayamaRHigaROcular hypotensive effects and safety over three months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combinationJ Ocul harmacol Ther201127581587
  • DiestelhorstMLarssonLIEuropean-Canadian Latanoprost Fixed Combination Study GroupA 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual componentsOphthalmology2006113707616263174
  • KitazawaYKP2035 Study GroupPhase III double-blind study of latanoprost/timolol combination (KP2035) in patients with primary open-angle glaucoma or ocular hypertensionRinsho Ganka200963807815 Japanese
  • DunkerSSchmuckerAMaierHTolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timololAdv Ther20072437638617565929
  • HamacherTSchinzelMSchölzel-KlattAShort term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapiesBr J Ophthalmol2004881295129815377554
  • PoloVLarrosaJMFerrerasAEffect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% administered in the evening in glaucomaAnn Ophthalmol200840157162
  • MiuraKItoKOkawaCComparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprostJ Glaucoma20081723323718414111
  • LiuJHKMedeirosFASlightJRComparison diurnal and nocturnal effects of brizolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapyOphthalmology200911644945419157559